Novartis to acquire Chinook Therapeutics in H2 2023

Swiss pharmaceutical giant, Novartis AG, revealed on Monday that it will acquire Seattle-based Chinook Therapeutics for $3.5 billion, with the transaction anticipated to finalize in the second half of…